There has been a great deal of news surrounding the research implicating gum disease in contributing to Alzheimer’s disease and dementia. It is through the lens of the antimicrobial approach to treating Alzheimer’s disease that the latest study suggesting that periodontal bacteria can play a role in Alzheimer’s disease should be ...
March 15, 2019
Cure Alzheimer’s Fund together with Janssen Alzheimer Immunotherapy and Pfizer is pleased to announce the addition of the National Family Caregivers Association (NFCA) to The 7 Summits Climb for Alzheimer’s: Memories are Everything campaign. NFCA joins just as alpine mountaineer and Alzheimer’s disease advocate Alan Arnette successfully summitted ...
February 3, 2011
Over the past few years, our understanding of Alzheimer’s disease has increased immensely. We can now identify three distinct parts of the disease pathology: early-stage Abeta (amyloid) accumulation, mid-stage development of tau tangles, and late-stage inflammation. Scientists on our Research Consortium are investigating all three of these points of intervention. On ...
March 21, 2014
“We all long for Eden, and we are constantly glimpsing it: our whole nature at its best and least corrupted, its gentlest and most human, is still soaked with the sense of exile.” J.R.R. TOLKIEN, THE LETTERS OF J.R.R. TOLKIEN I am soaked today in exile, as are others in ...
February 3, 2024
Research suggests Abeta is an antimicrobial peptide and that infection may trigger plaque buildup in the brains of Alzheimer’s patients Wellesley, Mass. (May 25, 2016) – A key protein found in the brain of Alzheimer’s disease patients is related to the body’s innate immune system – raising new questions about the ...
May 25, 2016
My late grandmother, Genevieve Madden, was a loving, intelligent, and quick-witted woman. Later in her life, she suffered from Alzheimer’s disease and when she eventually succumbed to the disease she was just a shell of her former self. The disease is cruel for those who suffer from it as well ...
August 12, 2015
Univ. of Pittsburgh’s Dr. William Klunk & MGH’s Dr. Rudolph Tanzi to Discuss Joint Effort At World Alzheimer’s Day University of Pittsburgh Forum Pittsburgh – Bringing together two esteemed institutions known for groundbreaking Alzheimer’s research, Cure Alzheimer’s Fund has awarded the University of Pittsburgh a $300,000 grant and Massachusetts General ...
September 22, 2010
October 12, 2023 – Cure Alzheimer’s Fund announces Josephine (Jo) Antonellis has been named Chief Financial Officer (CFO) and Julie Harris, Ph.D., has been named Executive Vice President, Research Management for the nonprofit organization. As CFO, Antonellis will be responsible for the financial management of the nonprofit organization, including leadership of ...
November 13, 2023
Last week, US News & World Report recognized one of our Research Consortium’s leading scientists – Dr. David Holtzman. In the article, Holtzman was hailed as one of the top researchers in the field: “He’s clearly one of the leaders in Alzheimer’s disease research,” says Stephen Snyder, deputy director of ...
July 6, 2009
Alzheimer’s disease (AD) is a significant public health challenge, as prevalence rises with an aging population and few, if any, treatments are effective at slowing disease progression. The vast majority of cases are late onset, and genetic sequencing reveals that these late-onset AD (LOAD) cases involve many weakly penetrant mutations that ...
December 15, 2020
